These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 15878273)

  • 1. Total asymmetric synthesis of (-)-conduramine B-1 and of its enantiomer. N-Benzyl derivatives of conduramine B-1 are beta-glucosidase inhibitors.
    Łysek R; Schütz C; Vogel P
    Bioorg Med Chem Lett; 2005 Jun; 15(12):3071-5. PubMed ID: 15878273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Search for alpha-glucosidase inhibitors: new N-substituted valienamine and conduramine F-1 derivatives.
    Łysek R; Schütz C; Favre S; O'Sullivan AC; Pillonel C; Krülle T; Jung PM; Clotet-Codina I; Esté JA; Vogel P
    Bioorg Med Chem; 2006 Sep; 14(18):6255-82. PubMed ID: 16797996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and α-Glucosidase II inhibitory activity of valienamine pseudodisaccharides relevant to N-glycan biosynthesis.
    Cumpstey I; Ramstadius C; Eszter Borbas K; Alonzi DS; Butters TD
    Bioorg Med Chem Lett; 2011 Sep; 21(18):5219-23. PubMed ID: 21840710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total synthesis and glycosidase inhibition of broussonetine I and J(2).
    Zhao H; Kato A; Sato K; Jia YM; Yu CY
    J Org Chem; 2013 Aug; 78(16):7896-902. PubMed ID: 23829312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chiral piperazine-2,5-dione derivatives as effective alpha-glucosidase inhibitors. Part 4.
    Arcelli A; Balducci D; Porzi G; Sandri M
    Chem Biodivers; 2010 Jan; 7(1):225-8. PubMed ID: 20087993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis of an alpha-fucosidase inhibitor, 5a-carba-beta-L-fucopyranosylamine, and fucose-type alpha- and beta-DL-valienamine unsaturated derivatives.
    Ogawa S; Watanabe M; Maruyama A; Hisamatsu S
    Bioorg Med Chem Lett; 2002 Mar; 12(5):749-52. PubMed ID: 11858994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. N-Substituted valienamines, alpha-glucosidase inhibitors.
    Kameda Y; Asano N; Yoshikawa M; Matsui K; Horii S; Fukase H
    J Antibiot (Tokyo); 1982 Nov; 35(11):1624-6. PubMed ID: 6761330
    [No Abstract]   [Full Text] [Related]  

  • 8. Asymmetric stereodivergent strategy towards aminocyclitols.
    Trost BM; Malhotra S
    Chemistry; 2014 Jul; 20(27):8288-92. PubMed ID: 24889256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Convenient synthesis and evaluation of glycosidase inhibitory activity of alpha- and beta-galactose-type valienamines, and some N-alkyl derivatives.
    Ogawa S; Sakata Y; Ito N; Watanabe M; Kabayama K; Itoh M; Korenaga T
    Bioorg Med Chem; 2004 Mar; 12(5):995-1002. PubMed ID: 14980612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New aminocyclitols as modulators of glucosylceramide metabolism.
    Egido-Gabás M; Serrano P; Casas J; Llebaria A; Delgado A
    Org Biomol Chem; 2005 Apr; 3(7):1195-201. PubMed ID: 15785807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel synthesis of natural pseudo-aminosugars, (+)-valienamine and (+)-validamine.
    Tatsuta K; Mukai H; Takahashi M
    J Antibiot (Tokyo); 2000 Apr; 53(4):430-5. PubMed ID: 10866227
    [No Abstract]   [Full Text] [Related]  

  • 12. A new synthesis of valienamine.
    Kok SH; Lee CC; Shing TK
    J Org Chem; 2001 Oct; 66(21):7184-90. PubMed ID: 11597249
    [No Abstract]   [Full Text] [Related]  

  • 13. Classification of some alpha-glucosidases and alpha-xylosidases on the basis of substrate specificity.
    Yoshikawa K; Yamamoto K; Okada S
    Biosci Biotechnol Biochem; 1994 Aug; 58(8):1392-8. PubMed ID: 7765271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enzymatic synthesis of glucoside derivatives of validamine and valienamine.
    Furumoto T; Kameda Y; Matsui K
    Chem Pharm Bull (Tokyo); 1992 Jul; 40(7):1871-5. PubMed ID: 1394706
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and α-glucosidase inhibitory activity evaluation of N-substituted aminomethyl-β-d-glucopyranosides.
    Bian X; Fan X; Ke C; Luan Y; Zhao G; Zeng A
    Bioorg Med Chem; 2013 Sep; 21(17):5442-50. PubMed ID: 23810673
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deactivation of cellulases by phenols.
    Ximenes E; Kim Y; Mosier N; Dien B; Ladisch M
    Enzyme Microb Technol; 2011 Jan; 48(1):54-60. PubMed ID: 22112771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and evaluation of calystegine B2 analogues as glycosidase inhibitors.
    García-Moreno MI; Benito JM; Ortiz Mellet C; García Fernández JM
    J Org Chem; 2001 Nov; 66(23):7604-14. PubMed ID: 11701011
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and synthesis of 5a-carbaglycopyranosylamime glycosidase inhibitors.
    Ogawa S; Kanto M
    Curr Top Med Chem; 2009; 9(1):58-75. PubMed ID: 19199996
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Valienamine as an alpha-glucosidase inhibitor.
    Kameda Y; Asano N; Yoshikawa M; Matsui K
    J Antibiot (Tokyo); 1980 Dec; 33(12):1575-6. PubMed ID: 6788743
    [No Abstract]   [Full Text] [Related]  

  • 20. Novel synthesis of dihydropyrimidines for α-glucosidase inhibition to treat type 2 diabetes: in vitro biological evaluation and in silico docking.
    Yar M; Bajda M; Shahzadi L; Shahzad SA; Ahmed M; Ashraf M; Alam U; Khan IU; Khan AF
    Bioorg Chem; 2014 Jun; 54():96-104. PubMed ID: 24880489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.